Phospholamban Ablation Using CRISPR/Cas9 System Improves Mortality in a Murine Heart Failure Model.

MLA

Kaneko, Manami, et al. “Phospholamban Ablation Using CRISPR/Cas9 System Improves Mortality in a Murine Heart Failure Model.” PloS One, vol. 11, no. 12, Dec. 2016, p. e0168486. EBSCOhost, https://doi.org/10.1371/journal.pone.0168486.

APA

Kaneko, M., Hashikami, K., Yamamoto, S., Matsumoto, H., & Nishimoto, T. (2016). Phospholamban Ablation Using CRISPR/Cas9 System Improves Mortality in a Murine Heart Failure Model. PloS One, 11(12), e0168486. https://doi.org/10.1371/journal.pone.0168486

Chicago

Kaneko, Manami, Kentarou Hashikami, Satoshi Yamamoto, Hirokazu Matsumoto, and Tomoyuki Nishimoto. 2016. “Phospholamban Ablation Using CRISPR/Cas9 System Improves Mortality in a Murine Heart Failure Model.” PloS One 11 (12): e0168486. doi:10.1371/journal.pone.0168486.